ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 666

Involvement Of TCR Vdelta1+ NKT Cells In Systemic Sclerosis: Association With Interstitial Pneumonia

Seiji Segawa1, Daisuke Goto2, Masanobu Horikoshi2, Yuya Kondo3, Naoto Umeda2, Shinya Hagiwara2, Masahiro Yokosawa4, Tomoya Hirota3, Haruka Miki1, Hiroto Tsuboi3, Hiroshi Ogishima2, Takeshi Suzuki4, Isao Matsumoto5 and Takayuki Sumida3, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 2Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba City, Japan, 3Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 4Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 5Department of Internal Medicine, Faculty of Medicine,, University of Tsukuba, Tsukuba, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: chemokines and systemic sclerosis, Lung Disease, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Interstitial pneumonia (IP) is one of the critical complications in patients with several autoimmune diseases. However, the exact mechanism of IP remains elusive. Recently, the pathological role of γδ T cells was reported in several IP mice models. Previous our data showed that IP in Interleukin (IL)-2 plus IL-18 induced mice was similar to human IP. In this mice model, γδNKT cells exacerbated IL-2 plus IL-18 induced lung inflammation via the production of IFN-γ. Thus, to examine whether TCR Vδ1+ NKT cells play a crucial role, we carried out the number and function of TCR Vδ1+ NKT cells in systemic sclerosis patients with IP.

Methods: 1) PBMCs were isolated from healthy controls (HC, n=22) and patients with rheumatoid arthritis (RA, n=17), systemic sclerosis (SSc, n=35), and polymyositis/dermatomyositis (PM/DM, n=14). We examined the proportion of TCR Vδ1+ NKT cells in PBMCs by flow cytometry (FCM). 2) In SSc patients with IP, the correlation between proportion of TCR Vδ1+ NKT cells in PBMCs and serum KL-6 levels was analyzed. 3) CD161– Vδ1+ γδT and CD161+ Vδ1+ γδT cells (TCR Vδ1+ NKT cells) in PBMCs were sorted out from HC (n=3). We performed GeneChip analysis using those two cell populations. 4) Cytokine (IFN-γ, TNF-α, IL-4, IL-17) and chemokine (CCL2, CCL3, CCL4, CCL5) secretion assay using TCR Vδ1+ NKT cells from HC and SSc patients was performed. 5) The effect of culture supernatant of TCR Vδ1+ NKT cells on fibroblast proliferation was evaluated.

Results: 1) The proportion of TCR Vδ1+ NKT cells in PBMCs from SSc patients (mean±SEM, 0.55±0.13%) was significantly higher than that of HC (0.23±0.09%, p<0.05), whereas RA (0.38±0.12%) and PM/DM patients (0.23±0.11%) were not. In SSc patients, the proportion of TCR Vδ1+ NKT cells in PBMCs from IP-negative subjects (1.03±0.32%) was significantly higher than that of IP-positive subjects (0.28±0.07%, p<0.05). In RA and PM/DM patients, there was no difference between IP-negative and IP-positive subjects. 2) In IP-positive SSc patients, the proportion of TCR Vδ1+ NKT cells correlated negatively with serum KL-6 values (r=-0.464, p<0.05). 3) 192 genes were highly expressed in TCR Vδ1+ NKT cells compared to CD161– Vδ1+ γδT cells. One of 192 genes was CCL3 chemokine associating with SSc and IP. 4) Upregulation of CCL3 and downregulation of IFN-γ production were noted in TCR Vδ1+ NKT cells of IP-positive SSc patients upon TCR stimulation compared with HC (p<0.05). 5) Fibroblast proliferation was promoted with medium supplemented with culture supernatant derived from IP-positive SSc patients (p<0.05), whereas that from HC was not.

Conclusion: TCR Vδ1+ NKT cells might play a regulatory role in the pathogenesis of IP in SSc patients.


Disclosure:

S. Segawa,
None;

D. Goto,
None;

M. Horikoshi,
None;

Y. Kondo,
None;

N. Umeda,
None;

S. Hagiwara,
None;

M. Yokosawa,
None;

T. Hirota,
None;

H. Miki,
None;

H. Tsuboi,
None;

H. Ogishima,
None;

T. Suzuki,
None;

I. Matsumoto,
None;

T. Sumida,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/involvement-of-tcr-vdelta1-nkt-cells-in-systemic-sclerosis-association-with-interstitial-pneumonia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology